SynthesisWorld journal of urology2026
Challenging recurrent ureteropelvic junction obstructions: endoscopic procedures versus redo-pyeloplasty-a systematic review and meta-analysis.
Synthesis in World journal of urology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionThe efficacy of endoscopic management of recurrent ureteropelvic junction obstruction (rUPJO) compared to redo pyeloplasty (RP) after primary intervention remains unclear. We performed a systematic review and meta-analysis (SR/MA) of comparative studies on endoscopic procedures (EP), specifically endopyelotomy or balloon dilation versus RP.
methodsWe conducted a PRISMA-compliant SR/MA registered in PROSPERO (CRD420251046758). We searched MEDLINE, Embase, Scopus, CINAHL, CENTRAL, and Web of Science without language or date restrictions (initial search in May 2025; updated in November 2025). Comparative studies evaluating EP versus RP for rUPJO were identified. Two reviewers performed screening, data extraction, and risk-of-bias assessment in duplicate. The outcomes assessed were treatment success (radiographic and/or functional patency, and/or symptom resolution) and perioperative complications. Subgroup analysis was conducted for adult vs pediatric patients. The Haenszel-Mantel Method with random-effects model meta-analyses generated pooled odds ratios (ORs) with 95% confidence intervals (CIs).
resultsA total of 1945 records were retrieved; ultimately, 12 studies with 549 patients (EP, n = 304; RP, n = 245) met the inclusion criteria. Definitions of success and follow-up duration varied across studies. Surgical approaches included open, laparoscopic, and robotic RP. EP techniques comprised endopyelotomy and balloon dilation, with selective use based on stricture length and vascular anatomy. Across all included comparative studies, RP demonstrated higher success than EP; the pooled effect size favored RP, with an OR of 6.32 (95% CI 3.25–12.32). Composite complication rates did not show a statistically significant difference between RP and EP 1.31 (95% CI 0.54–3.18). Secondary outcomes were heterogeneous but generally favored EP, including shorter operative time, shorter length of stay, and minimal blood loss. The heterogeneity among subgroups was low to moderate. The risk of bias assessment was determined to be high to serious, specifically due to confounders and retrospective designs, which introduced clinical selection bias and limited the overall quality of the evidence.
conclusionsFor rUPJO, RP was associated with higher odds of success than endoscopic management, without a demonstrable difference in complications. EP may be appropriate in carefully selected, favorable strictures; however, current comparative data support RP as the more reliable salvage option. Future work should prioritize standardized outcome definitions, prospective risk-adjusted comparisons, and transparent reporting of complication severity to refine patient selection and quantify trade-offs between approaches.
Indexed as
Identifiers
41870690What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.